GIJN’s member organizations re-elected four current board members whose terms expired in 2025, and also voted in three new board members.
The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct. A federal spokesperson said Dr. George Tidmarsh left the agency after ...